vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and Plymouth Industrial REIT, Inc. (PLYM). Click either name above to swap in a different company.

Plymouth Industrial REIT, Inc. is the larger business by last-quarter revenue ($51.2M vs $40.7M, roughly 1.3× PETMED EXPRESS INC). PETMED EXPRESS INC runs the higher net margin — -26.0% vs -106.3%, a 80.3% gap on every dollar of revenue. On growth, Plymouth Industrial REIT, Inc. posted the faster year-over-year revenue change (-1.4% vs -23.3%). Over the past eight quarters, Plymouth Industrial REIT, Inc.'s revenue compounded faster (0.4% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Plymouth Industrial REIT, Inc. is a real estate investment trust focused on owning, operating, and acquiring high-quality industrial properties including distribution centers, warehouses, and light industrial facilities across key U.S. logistics hubs. It serves tenants in e-commerce, retail, manufacturing, and third-party logistics sectors, supporting diverse business supply chain needs.

PETS vs PLYM — Head-to-Head

Bigger by revenue
PLYM
PLYM
1.3× larger
PLYM
$51.2M
$40.7M
PETS
Growing faster (revenue YoY)
PLYM
PLYM
+21.9% gap
PLYM
-1.4%
-23.3%
PETS
Higher net margin
PETS
PETS
80.3% more per $
PETS
-26.0%
-106.3%
PLYM
Faster 2-yr revenue CAGR
PLYM
PLYM
Annualised
PLYM
0.4%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q3 FY2025

Metric
PETS
PETS
PLYM
PLYM
Revenue
$40.7M
$51.2M
Net Profit
$-10.6M
$-54.4M
Gross Margin
23.3%
Operating Margin
-25.7%
-102.5%
Net Margin
-26.0%
-106.3%
Revenue YoY
-23.3%
-1.4%
Net Profit YoY
-1392.6%
-248.5%
EPS (diluted)
$-0.50
$-1.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
PLYM
PLYM
Q4 25
$40.7M
Q3 25
$44.4M
$51.2M
Q2 25
$51.2M
$47.2M
Q1 25
$50.8M
$45.6M
Q4 24
$52.0M
$47.6M
Q3 24
$58.0M
$51.9M
Q2 24
$66.2M
$48.7M
Q1 24
$65.1M
$50.2M
Net Profit
PETS
PETS
PLYM
PLYM
Q4 25
$-10.6M
Q3 25
$-8.5M
$-54.4M
Q2 25
$-34.2M
$-6.1M
Q1 25
$-11.6M
$5.8M
Q4 24
$-707.0K
$147.4M
Q3 24
$2.3M
$-15.6M
Q2 24
$3.8M
$1.3M
Q1 24
$-5.0M
$6.2M
Gross Margin
PETS
PETS
PLYM
PLYM
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
PETS
PETS
PLYM
PLYM
Q4 25
-25.7%
Q3 25
-18.9%
-102.5%
Q2 25
-66.7%
-10.3%
Q1 25
-11.9%
Q4 24
-0.9%
Q3 24
1.0%
-29.6%
Q2 24
6.6%
2.7%
Q1 24
-5.9%
Net Margin
PETS
PETS
PLYM
PLYM
Q4 25
-26.0%
Q3 25
-19.2%
-106.3%
Q2 25
-66.7%
-12.9%
Q1 25
-22.9%
12.8%
Q4 24
-1.4%
309.9%
Q3 24
4.0%
-30.1%
Q2 24
5.7%
2.7%
Q1 24
-7.7%
12.4%
EPS (diluted)
PETS
PETS
PLYM
PLYM
Q4 25
$-0.50
Q3 25
$-0.41
$-1.23
Q2 25
$-1.65
$-0.14
Q1 25
$-0.56
$0.13
Q4 24
$-0.03
$3.24
Q3 24
$0.11
$-0.35
Q2 24
$0.18
$0.03
Q1 24
$-0.24
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
PLYM
PLYM
Cash + ST InvestmentsLiquidity on hand
$26.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$32.8M
$470.1M
Total Assets
$88.0M
$1.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
PLYM
PLYM
Q4 25
$26.9M
Q3 25
$36.1M
Q2 25
$41.1M
Q1 25
$54.7M
Q4 24
$50.1M
Q3 24
$52.0M
Q2 24
$46.0M
Q1 24
$55.3M
Total Debt
PETS
PETS
PLYM
PLYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$646.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PETS
PETS
PLYM
PLYM
Q4 25
$32.8M
Q3 25
$43.1M
$470.1M
Q2 25
$51.5M
$539.6M
Q1 25
$85.1M
$571.0M
Q4 24
$96.2M
$579.5M
Q3 24
$96.4M
$436.5M
Q2 24
$93.5M
$475.2M
Q1 24
$96.7M
$484.6M
Total Assets
PETS
PETS
PLYM
PLYM
Q4 25
$88.0M
Q3 25
$100.3M
$1.6B
Q2 25
$109.8M
$1.6B
Q1 25
$148.7M
$1.4B
Q4 24
$144.8M
$1.4B
Q3 24
$146.0M
$1.5B
Q2 24
$152.7M
$1.4B
Q1 24
$169.9M
$1.4B
Debt / Equity
PETS
PETS
PLYM
PLYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
1.12×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
PLYM
PLYM
Operating Cash FlowLast quarter
$-9.2M
$20.0M
Free Cash FlowOCF − Capex
$-9.2M
FCF MarginFCF / Revenue
-22.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
PLYM
PLYM
Q4 25
$-9.2M
Q3 25
$-2.2M
$20.0M
Q2 25
$-12.3M
$23.4M
Q1 25
$7.0M
$15.6M
Q4 24
$-1.2M
$96.1M
Q3 24
$7.4M
$17.6M
Q2 24
$-8.5M
$19.9M
Q1 24
$7.1M
$16.6M
Free Cash Flow
PETS
PETS
PLYM
PLYM
Q4 25
$-9.2M
Q3 25
$-4.8M
Q2 25
$-13.6M
Q1 25
$4.6M
Q4 24
$-1.9M
Q3 24
$6.1M
Q2 24
$-9.2M
Q1 24
$5.9M
FCF Margin
PETS
PETS
PLYM
PLYM
Q4 25
-22.7%
Q3 25
-10.8%
Q2 25
-26.5%
Q1 25
9.1%
Q4 24
-3.7%
Q3 24
10.6%
Q2 24
-13.9%
Q1 24
9.0%
Capex Intensity
PETS
PETS
PLYM
PLYM
Q4 25
0.1%
Q3 25
5.9%
Q2 25
2.5%
Q1 25
4.7%
Q4 24
1.5%
Q3 24
2.2%
Q2 24
1.0%
Q1 24
1.9%
Cash Conversion
PETS
PETS
PLYM
PLYM
Q4 25
Q3 25
Q2 25
Q1 25
2.67×
Q4 24
0.65×
Q3 24
3.18×
Q2 24
-2.27×
15.12×
Q1 24
2.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

PLYM
PLYM

Segment breakdown not available.

Related Comparisons